InvestorsHub Logo
Followers 71
Posts 9394
Boards Moderated 0
Alias Born 07/17/2013

Re: AlanC post# 120486

Saturday, 08/29/2015 11:15:21 AM

Saturday, August 29, 2015 11:15:21 AM

Post# of 402811
I agree with Karin when she said "The meaningless numbers posted daily causes fear. The price has been walked down daily starting a couple days from the first posting of such numbers. It causes fear for those that don't understand what they are reading.

Many that read these numbers run from a stock if they happen to believe them.

The postings of these meaningless numbers has facilitated the needs of the author of the hit piece who stated "Disclosure: I am/we are short CTIX."

People should simply ignore these numbers posted daily. They are meaningless in the context most use them for on these boards.

Thankfully, any successfully completed trials should solve this problem. Kevetrin phase I safety trial appears to be coming to a successful close. Plus, it is showing tantalizing hints of efficacy. I look forward to the start of the phase II's coming up. The company will likely have a phase II for ovarian cancer patients and UoB Italy will be conducting a phase II on AML.

The company has been adding trial sites to both current phase II trials in an apparent effort to speed them up. Prurisol and Brilacidin-OM.

https://clinicaltrials.gov/ct2/results?term=cellceutix

The share price won't be staying weak as results start coming out. I expect a partnership if/after Brilacidin-OM phase II shows positive results. Unlike the Kevetrin oncology trial, this one should be relatively quick. Especially, with the addition of trial sites."

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=116541584

In response to AlanC as follows:

AlanC Member Level Grandfathered Member Friday, 08/28/15 10:47:38 PM
Re: JUST 10-11-12 post# 120481
Post # of 120512
FINRA short sales of CTIX
20150828|CTIX|54365|0|92637|O
59% of today's volume was short sales!
Go CTIX!!!


As always, in my opinion only. Do your own due diligence!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News